Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://mariamdmjm716120.dsiblogger.com/71909051/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide